Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 1
1959 3
1961 6
1962 3
1963 2
1964 8
1965 1
1966 6
1967 4
1968 3
1969 6
1970 2
1971 3
1972 5
1973 9
1974 16
1975 16
1976 11
1977 11
1978 10
1979 12
1980 7
1981 19
1982 11
1983 20
1984 15
1985 21
1986 20
1987 24
1988 16
1989 19
1990 33
1991 52
1992 50
1993 53
1994 64
1995 56
1996 49
1997 52
1998 56
1999 60
2000 64
2001 42
2002 47
2003 62
2004 33
2005 43
2006 45
2007 68
2008 75
2009 69
2010 80
2011 73
2012 88
2013 87
2014 82
2015 103
2016 101
2017 105
2018 98
2019 84
2020 110
2021 123
2022 97
2023 112
2024 90
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,606 results

Results by year

Filters applied: . Clear all
Page 1
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation.
Tadokoro T, Murata S, Kato M, Ueno Y, Tsuchida T, Okumura A, Kuse Y, Konno T, Uchida Y, Yamakawa Y, Zushi M, Yajima M, Kobayashi T, Hasegawa S, Kawakatsu-Hatada Y, Hayashi Y, Osakabe S, Maeda T, Kimura K, Mori A, Tanaka M, Kamishibahara Y, Matsuo M, Nie YZ, Okamoto S, Oba T, Tanimizu N, Taniguchi H. Tadokoro T, et al. Among authors: mori a. Sci Transl Med. 2024 Jul 24;16(757):eadg0338. doi: 10.1126/scitranslmed.adg0338. Epub 2024 Jul 24. Sci Transl Med. 2024. PMID: 39047116
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up.
Rugo HS, Finn RS, Diéras V, Ettl J, Lipatov O, Joy AA, Harbeck N, Castrellon A, Iyer S, Lu DR, Mori A, Gauthier ER, Bartlett CH, Gelmon KA, Slamon DJ. Rugo HS, et al. Among authors: mori a. Breast Cancer Res Treat. 2019 Apr;174(3):719-729. doi: 10.1007/s10549-018-05125-4. Epub 2019 Jan 10. Breast Cancer Res Treat. 2019. PMID: 30632023 Free PMC article. Clinical Trial.
Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells.
Takebe T, Sekine K, Kimura M, Yoshizawa E, Ayano S, Koido M, Funayama S, Nakanishi N, Hisai T, Kobayashi T, Kasai T, Kitada R, Mori A, Ayabe H, Ejiri Y, Amimoto N, Yamazaki Y, Ogawa S, Ishikawa M, Kiyota Y, Sato Y, Nozawa K, Okamoto S, Ueno Y, Taniguchi H. Takebe T, et al. Among authors: mori a. Cell Rep. 2017 Dec 5;21(10):2661-2670. doi: 10.1016/j.celrep.2017.11.005. Cell Rep. 2017. PMID: 29212014 Free article.
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.
Rugo HS, Diéras V, Gelmon KA, Finn RS, Slamon DJ, Martin M, Neven P, Shparyk Y, Mori A, Lu DR, Bhattacharyya H, Bartlett CHUANG, Iyer S, Johnston S, Ettl J, Harbeck N. Rugo HS, et al. Among authors: mori a. Ann Oncol. 2018 Apr 1;29(4):888-894. doi: 10.1093/annonc/mdy012. Ann Oncol. 2018. PMID: 29360932 Free PMC article. Clinical Trial.
Adenosine, adenosine A 2A antagonists, and Parkinson's disease.
Jenner P, Mori A, Hauser R, Morelli M, Fredholm BB, Chen JF. Jenner P, et al. Among authors: mori a. Parkinsonism Relat Disord. 2009 Jul;15(6):406-13. doi: 10.1016/j.parkreldis.2008.12.006. Epub 2009 May 15. Parkinsonism Relat Disord. 2009. PMID: 19446490 Review.
A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.
Sassi G, Licata G, Ventriglia G, Wouters A, Lemaitre P, Seurinck R, Mori A, Grieco GE, Bissenova S, Ellis D, Caluwaerts S, Rottiers P, Vandamme N, Mathieu C, Dotta F, Gysemans C, Sebastiani G. Sassi G, et al. Among authors: mori a. Diabetes. 2023 Oct 1;72(10):1470-1482. doi: 10.2337/db22-0852. Diabetes. 2023. PMID: 37494666 Free PMC article.
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Chiba K, et al. Among authors: mori a. Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6. Bone. 2022. PMID: 35398293 Free article. Clinical Trial.
2,606 results